Your browser doesn't support javascript.
loading
Preoperative oral antibiotic prophylaxis reduces Pseudomonas aeruginosa surgical site infections after elective colorectal surgery: a multicenter prospective cohort study.
Gomila, A; Carratalà, J; Badia, J M; Camprubí, D; Piriz, M; Shaw, E; Diaz-Brito, V; Espejo, E; Nicolás, C; Brugués, M; Perez, R; Lérida, A; Castro, A; Biondo, S; Fraccalvieri, D; Limón, E; Gudiol, F; Pujol, M.
Afiliação
  • Gomila A; Department of Infectious Diseases, Hospital Universitari de Bellvitge, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Feixa Llarga s/n, 08907 L'Hospitalet de Llobregat, Barcelona, Spain. agomilagrange@gmail.com.
  • Carratalà J; VINCat Program, Barcelona, Spain. agomilagrange@gmail.com.
  • Badia JM; Department of Infectious Diseases, Hospital Universitari de Bellvitge, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Feixa Llarga s/n, 08907 L'Hospitalet de Llobregat, Barcelona, Spain.
  • Camprubí D; VINCat Program, Barcelona, Spain.
  • Piriz M; University of Barcelona, Barcelona, Spain.
  • Shaw E; VINCat Program, Barcelona, Spain.
  • Diaz-Brito V; Department of General Surgery, Hospital General de Granollers, Barcelona, Spain.
  • Espejo E; Universitat Internacional de Catalunya, Barcelona, Spain.
  • Nicolás C; Department of Infectious Diseases, Hospital Universitari de Bellvitge, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Feixa Llarga s/n, 08907 L'Hospitalet de Llobregat, Barcelona, Spain.
  • Brugués M; VINCat Program, Barcelona, Spain.
  • Perez R; VINCat Program, Barcelona, Spain.
  • Lérida A; Department of Infectious Diseases, Corporació Sanitària Parc Taulí, Barcelona, Spain.
  • Castro A; Department of Infectious Diseases, Hospital Universitari de Bellvitge, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Feixa Llarga s/n, 08907 L'Hospitalet de Llobregat, Barcelona, Spain.
  • Biondo S; VINCat Program, Barcelona, Spain.
  • Fraccalvieri D; VINCat Program, Barcelona, Spain.
  • Limón E; Department of Infectious Diseases, Parc Sanitari Sant Joan de Déu, Barcelona, Spain.
  • Gudiol F; VINCat Program, Barcelona, Spain.
  • Pujol M; Department of Infectious Diseases, Consorci Sanitari de Terrassa, Barcelona, Spain.
BMC Infect Dis ; 18(1): 507, 2018 Oct 05.
Article em En | MEDLINE | ID: mdl-30290773
ABSTRACT

BACKGROUND:

Healthcare-associated infections caused by Pseudomonas aeruginosa are associated with poor outcomes. However, the role of P. aeruginosa in surgical site infections after colorectal surgery has not been evaluated. The aim of this study was to determine the predictive factors and outcomes of surgical site infections caused by P. aeruginosa after colorectal surgery, with special emphasis on the role of preoperative oral antibiotic prophylaxis.

METHODS:

We conducted an observational, multicenter, prospective cohort study of all patients undergoing elective colorectal surgery at 10 Spanish hospitals (2011-2014). A logistic regression model was used to identify predictive factors for P. aeruginosa surgical site infections.

RESULTS:

Out of 3701 patients, 669 (18.1%) developed surgical site infections, and 62 (9.3%) of these were due to P. aeruginosa. The following factors were found to differentiate between P. aeruginosa surgical site infections and those caused by other microorganisms American Society of Anesthesiologists' score III-IV (67.7% vs 45.5%, p = 0.001, odds ratio (OR) 2.5, 95% confidence interval (95% CI) 1.44-4.39), National Nosocomial Infections Surveillance risk index 1-2 (74.2% vs 44.2%, p < 0.001, OR 3.6, 95% CI 2.01-6.56), duration of surgery ≥75thpercentile (61.3% vs 41.4%, p = 0.003, OR 2.2, 95% CI 1.31-3.83) and oral antibiotic prophylaxis (17.7% vs 33.6%, p = 0.01, OR 0.4, 95% CI 0.21-0.83). Patients with P. aeruginosa surgical site infections were administered antibiotic treatment for a longer duration (median 17 days [interquartile range (IQR) 10-24] vs 13d [IQR 8-20], p = 0.015, OR 1.1, 95% CI 1.00-1.12), had a higher treatment failure rate (30.6% vs 20.8%, p = 0.07, OR 1.7, 95% CI 0.96-2.99), and longer hospitalization (median 22 days [IQR 15-42] vs 19d [IQR 12-28], p = 0.02, OR 1.1, 95% CI 1.00-1.17) than those with surgical site infections due to other microorganisms. Independent predictive factors associated with P. aeruginosa surgical site infections were the National Nosocomial Infections Surveillance risk index 1-2 (OR 2.3, 95% CI 1.03-5.40) and the use of oral antibiotic prophylaxis (OR 0.4, 95% CI 0.23-0.90).

CONCLUSIONS:

We observed that surgical site infections due to P. aeruginosa are associated with a higher National Nosocomial Infections Surveillance risk index, poor outcomes, and lack of preoperative oral antibiotic prophylaxis. These findings can aid in establishing specific preventive measures and appropriate empirical antibiotic treatment.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por Pseudomonas / Infecção da Ferida Cirúrgica / Antibacterianos Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: BMC Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por Pseudomonas / Infecção da Ferida Cirúrgica / Antibacterianos Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: BMC Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Espanha